Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

AnPac Bio-Medical Science Co., Ltd. (ANPC)

8.68   -0.09 (-1.03%) 02-02 15:59
Open: 9 Pre. Close: 8.77
High: 9.1 Low: 8.51
Volume: 13,154 Market Cap: 18(M)

Technical analysis

as of: 2023-02-02 4:28:46 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 14     One year: 16.35
Support: Support1: 6.92    Support2: 3.79
Resistance: Resistance1: 11.98    Resistance2: 14
Pivot: 8.35
Moving Average: MA(5): 8.53     MA(20): 7.66
MA(100): 4.52     MA(250): 6.32
MACD: MACD(12,26): 1     Signal(9): 1
Stochastic oscillator: %K(14,3): 47.7     %D(3): 47.4
RSI: RSI(14): 62.4
52-week: High: 18.65  Low: 0.25
Average Vol(K): 3-Month: 38 (K)  10-Days: 47 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ANPC ] has closed below upper band by 41.0%. Bollinger Bands are 75.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 17 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.11 - 9.16 9.16 - 9.21
Low: 8.4 - 8.45 8.45 - 8.5
Close: 8.6 - 8.69 8.69 - 8.77

Company Description

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Headline News

Thu, 02 Feb 2023
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and ... - InvestorPlace

Wed, 01 Feb 2023
Why TransCode Therapeutics Shares Are Trading Higher By 42 ... - Investing.com UK

Wed, 01 Feb 2023
Premarket Mover: AnPac Bio-Medical Science Co Ltd - ADR (ANPC) Down 14.37% - InvestorsObserver

Tue, 31 Jan 2023
Computer model predicts who will recover from COVID-19 - Medical Xpress

Mon, 30 Jan 2023
Togo Floods Operational Update (MDRTG009) - Togo - ReliefWeb

Thu, 26 Jan 2023
TOGO: In Dapaong, a school manual for natural disaster prevention - AFRIK 21

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 2 (M)
% Held by Insiders 1.78e+006 (%)
% Held by Institutions 7.2 (%)
Shares Short 92 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.371e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -491.5
Return on Assets (ttm) -69.9
Return on Equity (ttm) -2
Qtrly Rev. Growth 1.591e+007
Gross Profit (p.s.) 33.96
Sales Per Share 752.46
EBITDA (p.s.) 9.35115e+006
Qtrly Earnings Growth -1.1
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0.01
Price to Cash Flow -7.07

Stock Dividends

Dividend 0
Forward Dividend 90270
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.